Financing round brings in $20M for maker of genetic research tools

RainDance Technologies, which specializes in developing genetic research tools, secured $20 million in a Series E funding round. The Massachusetts-based firm plans to use the money to widen the reach of its products including its ThunderStorm sequencing and RainDrop digital PCR technologies. Proceeds will also go toward commercial operations and the expansion of production capacity.

View Full Article in:

Boston Herald · GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI